Now showing items 1-4 of 4

    • Advances in Tumor Screening, Imaging, and Avatar Technologies for High-Grade Serous Ovarian Cancer 

      Ohman, Anders W.; Hasan, Noor; Dinulescu, Daniela M. (Frontiers Media S.A., 2014)
      The majority of high-grade serous ovarian carcinoma cases are detected in advanced stages when treatment options are limited. Surgery is less effective at eradicating the disease when it is widespread, resulting in high ...
    • Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery 

      Pitteri, Sharon J.; JeBailey, Lellean; Faça, Vitor M.; Thorpe, Jason D.; Silva, Melissa A.; Ireton, Reneé C.; Horton, Marc B.; Pruitt, Liese C.; Urban, Nicole; Hanash, Samir M.; Nordheim, Alfred; Wang, Hong; Zhang, Qing; Cheng, Yu-Kang; Dinulescu, Daniela M (Public Library of Science, 2009)
      Background: The complexity of the human plasma proteome represents a substantial challenge for biomarker discovery. Proteomic analysis of genetically engineered mouse models of cancer and isolated cancer cells and cell ...
    • A Mouse Plasma Peptide Atlas as a Resource for Disease Proteomics 

      Menon, Rajasree; Deutsch, Eric W; Pitteri, Sharon J; Faca, Vitor M; Newcomb, Lisa F; Bardeesy, Nabeel; Hung, Kenneth E; Jacks, Tyler; Politi, Katerina; Aebersold, Ruedi; Omenn, Gilbert S; States, David J; Hanash, Samir M; Zhang, Qing; Wang, Hong; DePinho, Ronald A.; Dinulescu, Daniela M; Kucherlapati, Raju (BioMed Central, 2008)
      We present an in-depth analysis of mouse plasma leading to the development of a publicly available repository composed of 568 liquid chromatography-tandem mass spectrometry runs. A total of 13,779 distinct peptides have ...
    • “Take it up a NOTCH": Novel Strategies for Cancer Therapy 

      Morgan, Stefanie L.; Wyant, Gregory A.; Dinulescu, Daniela M (Landes Bioscience, 2013)